Integra Lifesciences Holdings earnings were -$7.2M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest IART earnings report on Jun 30, 2026 announced Q2 2026 earnings of $4.5M, down 197.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IART reported annual earnings of -$516.5M, with 7,337.7% growth.
Integra Lifesciences Holdings Earnings Reports & History FAQ
What were Integra Lifesciences Holdings's earnings last quarter?
On IART's earnings call on Jul 29, 2026, Integra Lifesciences Holdings (NASDAQ: IART) reported Q2 2026 earnings per share (EPS) of $0.06, up 100.95% year over year. Total IART earnings for the quarter were $4.48 million. In the same quarter last year, Integra Lifesciences Holdings's earnings per share (EPS) was -$6.31.
Is Integra Lifesciences Holdings profitable or losing money?
As of the last Integra Lifesciences Holdings earnings report, Integra Lifesciences Holdings is currently losing money. Integra Lifesciences Holdings's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$7.24 million, a 98.55% decrease year over year.
What was IART's earnings growth in the past year?
As of Integra Lifesciences Holdings's earnings date in Jul 29, 2026, Integra Lifesciences Holdings's earnings has grown year over year. IART earnings in the past year totalled -$7.24 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.